Binding HOA secured with Pro Medicus Limited
| Stock | Echoiq Ltd (EIQ.ASX) |
|---|---|
| Release Time | 25 Jun 2026, 8:51 a.m. |
| Price Sensitive | Yes |
Echo IQ secures strategic investment from Pro Medicus
- Binding Heads of Agreement with Pro Medicus for up to A$20 million investment
- Pro Medicus to become reseller of Echo IQ's products in the US
- Investment conditional on FDA clearance of EchoSolv HF
- Partnership aims to accelerate US commercialization of Echo IQ's AI technology
Echo IQ Limited has executed a binding Heads of Agreement with global health imaging company Pro Medicus Limited, establishing a framework for a proposed strategic investment and commercial partnership. Under the agreement, Pro Medicus will provide an initial A$10 million investment in Echo IQ, with an option to invest an additional A$10 million upon FDA clearance of EchoSolv HF. The partnership also includes a reseller arrangement where Pro Medicus will distribute Echo IQ's products to its extensive US healthcare network. This strategic partnership aims to leverage Pro Medicus' enterprise healthcare footprint and commercial reach with Echo IQ's AI-powered cardiac disease detection capabilities, potentially accelerating the adoption of EchoSolv across the US market.
Initial investment of A$10 million; additional A$10 million conditional on FDA clearance
The proposed partnership aims to accelerate the commercialization of Echo IQ's AI-powered cardiac diagnostic solutions in the US, leveraging Pro Medicus' extensive healthcare network.